Clinical Trials Directory

Trials / Completed

CompletedNCT04974164

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

Effectiveness of COVID-19 Vaccine (Vero Cell), Inactivated (CoronaVac) for Preventing Symptomatic SARS-CoV-2 Infections and Hospitalizations in the Dominican Republic - Test-Negative Case-Control Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,400 (actual)
Sponsor
Sinovac Research and Development Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is a multisite ,grouped test-negative case-control , phase Ⅳ clinical trial of an inactivated SARS-CoV-2 vaccine (CoronaVac) manufactured by Sinovac Research and Development Co., Ltd.The purpose of this study is to estimate the protective effectiveness of complete vaccination (measured ≥14 days after the second dose) of CoronaVac against symptomatic SARS-COV-2 infections ,COVID-19 hospitalizations and severe cases.

Detailed description

This study is a multisite,grouped test-negative case-control , phase Ⅳ clinical trial in population aged 18 years and older. The experimental vaccine will be manufactured by Sinovac Research and Development Co.,Ltd.The study is planned to be carried out in ten (10) selected hospitals and their catchment communities in five provinces of the Dominican Republic (DR): National District, La Altagracia, Puerto Plata, Santiago, and Santo Domingo from July 1, 2021 to April 30, 2022 . A total of 1400 subjects will be enrolled with 700 estimated clinic cases who are diagnosed as SARS-CoV-2 infection by real-time polymerase chain reaction (RT-PCR); and 700 estimated clinic controls who have a negative RT-PCR test.And subjects will receive two doses of vaccine for primary immunization .

Conditions

Interventions

TypeNameDescription
BIOLOGICALInactivated COVID-19 VaccineEach vial contains 0.5 mL (a single dose) and contains 600SU of inactivated SARS-CoV-2 virus antigen

Timeline

Start date
2021-08-17
Primary completion
2021-10-17
Completion
2021-12-13
First posted
2021-07-23
Last updated
2022-08-23

Locations

10 sites across 1 country: Dominican Republic

Source: ClinicalTrials.gov record NCT04974164. Inclusion in this directory is not an endorsement.